MedPath

A multicenter retrospective study comparing the safety and efficacy of carbon ion radiotherapy and radiofrequency ablation in early stage hepatocellular carcinoma

Not Applicable
Conditions
Hepatocellular carcinoma
Registration Number
JPRN-UMIN000047923
Lead Sponsor
Chiba university
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
631
Inclusion Criteria

Not provided

Exclusion Criteria

Patients with evidence of vascular invasion or distant metastasis. Patients with advanced carcinoma at the time of initial diagnosis of hepatocellular carcinoma. Patients with Child-Pugh C at the time of diagnosis of initial hepatocellular carcinoma. Patients who refuse to participate in this study.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Overall survival
Secondary Outcome Measures
NameTimeMethod
Progression free survival Local control Complications ALBI score after six months of treatment
© Copyright 2025. All Rights Reserved by MedPath